Neuropathic Pain Market Size, Share, Top Manufacturers, Latest Trends, Future Prospects and Forecast 2027
Neuropathic Pain Market |
The most prevalent cause of neuropathic pain is diabetes. Because the incidence of painful diabetic neuropathy is 16 percent in the worldwide aged population suffering from diabetes, an increase in the geriatric population is predicted to stimulate demand for neuropathic pain treatment services. The worldwide Neuropathic Pain Market Analysis is predicted to rise due to an increase in the incidence of diabetes and cancer, approval of innovative treatment options for neuropathic pain, an increase in the number of pain management clinics, and an increase in demand for treatment of neuropathic pain. Other factors are fueling the market's fast expansion.
Market Segmentation:
By Drug Class
- Tricyclic Antidepressants
- Opioids
- Capsaicin Cream
- Steroids
- Others
By Indication
- Diabetic Neuropathy
- Spinal Stenosis
- Chemotherapy-induced Peripheral Neuropathy
By Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Others
Players in the market could expect profitable growth possibilities due to the high prevalence of neuropathic-like pain in psoriatic arthritis. Researchers from Cardiff University in the United Kingdom, for example, revealed in July 2019 that neuropathic-like pain as evidence of aberrant pain processing is widespread in people with psoriatic arthritis.
The major players operating in the global neuropathic pain market include, Pfizer, Inc., Johnson & Johnson Services, Inc., Sanofi S.A., Eily Lily and Company, GlaxoSmithKline PLC, Biogen Idec., Bristol-Myers Squibb, Baxter Healthcare Corporation, and Depomed, Inc.
Source Links:
https://www.globenewswire.com/en/news-release/2020/05/25/2038154/0/en/Neuropathic-Pain-Market-to-reach-US-9-862-3-Million-globally-by-2027-Coherent-Market-Insights.html
https://www.medgadget.com/2021/05/neuropathic-pain-market-report-2021-to-register-a-cagr-of-6-4-to-reach-us-9862-3-million-by-2027-global-industry-analysis-growth-size-companies-revenue.html
Source Links:
https://www.globenewswire.com/en/news-release/2020/05/25/2038154/0/en/Neuropathic-Pain-Market-to-reach-US-9-862-3-Million-globally-by-2027-Coherent-Market-Insights.html
https://www.medgadget.com/2021/05/neuropathic-pain-market-report-2021-to-register-a-cagr-of-6-4-to-reach-us-9862-3-million-by-2027-global-industry-analysis-growth-size-companies-revenue.html
Comments
Post a Comment